Latest Earnings Analysis
-
Vinci Partners (VINP) Q2 2025: Fee-Related Revenue Surges 85% as Credit and Alternatives Drive Multi-Strategy Momentum
August 13, 2025 · VINP
-
Consumer Portfolio Services (CPSS) Q2 2025: Originations Hit $433M as Cost Discipline Lowers OpEx to Decade Low
August 13, 2025 · CPSS
-
EVE Air Mobility (SPNS) Q2 2025: $14B Backlog Anchors 2027 Service Entry, Prototype Flight Nears
August 13, 2025 · SPNS
-
IDN Q2 2025: Banking Revenue Up 85% YoY Offsets Retail Decline, Channel Strategy Expands Reach
August 13, 2025 · IDN
-
ANTA (ANTA) Q2 2025: Margin Loan TVL Jumps 50% as Collateral Innovation Expands TAM
August 13, 2025 · ANTA
-
Marchex (MCHX) Q2 2025: Engage Platform Drives Sequential ACV Growth as Migration Nears Completion
August 13, 2025 · MCHX
-
Prairie Operating (PROP) Q2 2025: Production Surges 540% as M&A and Cost Discipline Reshape Trajectory
August 13, 2025 · PROP
-
Double Down Interactive (DDI) Q2 2025: SuperNation iGaming Revenue Doubles, Fueling Diversification Push
August 13, 2025 · DDI
-
Intapp (INTA) Q4 2025: Cloud ARR Jumps 29% as AI and Enterprise Push Drive Expansion
August 13, 2025 · INTA
-
CAVA (CAVA) Q2 2025: New Restaurant Cohorts Drive 40%+ Cash Returns, Cementing Expansion Model
August 13, 2025 · CAVA
-
CVV Q2 2025: Orders Drop 57% as Tariff Uncertainty and Funding Cuts Pressure Backlog
August 13, 2025 · CVV
-
Journey Medical (DERM) Q2 2025: Amrosi Drives $2.8M Launch, Lifts Gross Margin to 67%
August 13, 2025 · DERM
-
Grail (GRAL) Q2 2025: Gallery Repeat Testing Climbs to 25%, Powering Evidence-Driven Expansion
August 13, 2025 · GRAL
-
Voyager Technologies (VYGR) Q2 2025: Defense and National Security Revenue Surges 85%, Reinforcing Platform Leverage
August 13, 2025 · VYGR
-
Inovio (INO) Q2 2025: Operating Expenses Drop 31% as 3107 Nears BLA Submission
August 13, 2025 · INO
-
PublicSq. (PSQH) Q2 2025: FinTech Revenue Jumps 80% as Strategic Pivot Accelerates
August 13, 2025 · PSQH
-
Zevra (ZVRA) Q2 2025: MyPlypha Drives 26% Sequential Revenue Growth, Expands Rare Disease Reach
August 13, 2025 · ZVRA
-
Pixelworks (PXLW) Q2 2025: Operating Expenses Down $3M, Cost Structure Reset Drives Near-Term Flexibility
August 13, 2025 · PXLW
-
Lumentum (LITE) Q4 2025: Cloud & Networking Jumps 67% as AI Demand Drives Supply Constraints
August 13, 2025 · LITE
-
Rigetti (RGTI) Q2 2025: Chiplet Milestone Slashes Error Rate 2x, Pushing Toward Quantum Advantage
August 12, 2025 · RGTI
-
Theravance Biopharma (TBPH) Q2 2025: UPLRI Sales Jump 22% as Cypress Nears Key Catalyst
August 12, 2025 · TBPH
-
Stoke Therapeutics (STOK) Q2 2025: 36-Month Cognition Gains Anchor Zareva-Nursen’s Disease-Modifying Case
August 12, 2025 · STOK
-
NeuroPace (NPCE) Q2 2025: Gross Margin Rises to 77.1% as RNS Platform Momentum Accelerates
August 12, 2025 · NPCE
-
Pulse Biosciences (PLSE) Q2 2025: R&D Spend to Rise with Two IDE Trials and Commercial Launch
August 12, 2025 · PLSE
-
Webtoon (WBTN) Q2 2025: Disney Deal Unlocks 100+ IP Titles, Fuels Platform Monetization Ambitions
August 12, 2025 · WBTN
-
Fathom Holdings (FTHM) Q2 2025: Elevate Agents Drive 4x Gross Profit, Anchoring Platform Margin Expansion
August 12, 2025 · FTHM
-
KinderCare (KLC) Q2 2025: Net Income Jumps 35% as B2B and Subsidy Tailwinds Offset Enrollment Dip
August 12, 2025 · KLC
-
Fractal Health (GUTS) Q2 2025: $23M Capital Raise Extends Runway Through Critical Revita Data Milestones
August 12, 2025 · GUTS
-
Abcide (ABSI) Q2 2025: $64M Capital Raise Extends Runway, Puts ABS-201 on Accelerated Path
August 12, 2025 · ABSI
-
Sparrow Therapeutics (SPRO) Q2 2025: PIVOT-PO Early Stop Triggers $13M R&D Savings, Extends Cash Runway to 2028
August 12, 2025 · SPRO
-
Lineage Cell Therapeutics (LCTX) Q2 2025: $14.8M Non-Cash Impairment Spotlights Pipeline Refocus and Platform Leverage
August 12, 2025 · LCTX
-
Surf Air Mobility (SRFM) Q2 2025: Completion Factor Hits 95%, Unlocking Operational and Software Leverage
August 12, 2025 · SRFM
-
IZEA (IZEA) Q2 2025: Operating Expenses Drop 41%, Unlocking First-Ever Profitability
August 12, 2025 · CURR
-
Mineralis (MLYS) Q2 2025: $324.9M Cash Position Extends Runway Beyond Pivotal Lorundrastat Milestones
August 12, 2025 · MLYS
-
IZEA (IZEA) Q2 2025: Cost Cuts Slash OpEx 41%, Unlocking First-Ever Operating Profit
August 12, 2025 · IZEA
-
SoundThinking (SSTI) Q2 2025: $37M Pipeline Fuels Post-Chicago Growth Strategy
August 12, 2025 · SSTI
-
GCT Semiconductor (GCTS) Q2 2025: 5G Chipset ASP Set to Quadruple Legacy Levels as Production Ramps
August 12, 2025 · GCTS
-
Trisalis Life Sciences (TLSI) Q2 2025: TriNavFlex Launch Fuels 52% Revenue Surge and Expands Clinical Reach
August 12, 2025 · TLSI
-
Spectral AI (MDAI) Q2 2025: $10.5M Cash Bolsters FDA Commercialization Runway
August 12, 2025 · MDAI
-
Lightbridge (LTBR) Q2 2025: Cash Position Surges to $98M, Accelerating Advanced Fuel Roadmap
August 12, 2025 · LTBR
-
PennantPark (PNNT) Q3 2025: $55M Spillover Income Bridges Dividend Amid Equity Rotation
August 12, 2025 · PNNT
-
Westport Fuel Systems (WPRT) Q2 2025: $62.5M Light Duty Divestiture Reshapes Strategic Focus
August 12, 2025 · WPRT
-
IFS (IFS) Q2 2025: ROE Tops 20% as Wealth Management, Insurance Drive Diversification
August 12, 2025 · IFS
-
Celanese (CE) Q2 2025: Western Hemisphere Volumes Drop to 20-Year Lows, Forcing Deeper Cost Action
August 12, 2025 · CE
-
PennantPark Floating Rate Capital (PFLT) Q3 2025: New $500M JV Signals 12-18 Month Deployment Ramp
August 12, 2025 · PFLT
-
KBDC Q2 2025: Broadly Syndicated Loan Book Falls Below $80M as Private Credit Rotation Accelerates
August 12, 2025 · KBDC
-
Net Power (NPWR) Q2 2025: Project Permian LCOE Falls Below $100, Unlocking Sequencing Upside
August 12, 2025 · NPWR
-
Anavex Life Sciences (AVXL) Q3 2025: $101M Cash Runway Extends Over 3 Years as EMA Decision Nears
August 12, 2025 · AVXL
-
Tencent Music (TME) Q2 2025: Subscription Revenue Jumps 17% as SVIP Base Surpasses 15M
August 12, 2025 · TME
-
Eagle Point Income (EIC) Q2 2025: $6.5M Buyback at 6.4% Discount Signals Capital Deployment Shift
August 12, 2025 · EIC